Tag: daxibotulinumtoxina

All

Revance Reports Q4 and Full Year 2021 Financial Results; Credits Dermal Filler Sales for Growth

The company also announced progress on its DaxibotulinumtoxinA for Injection for glabellar lines and intent to launch the RHA Redensity dermal filler in the second half of 2022.

Revance Resubmits BLA to FDA for DaxibotulinumtoxinA for Injection
Aesthetic Surgeon Shares Insights on DAXI’s Potential
Letybo, a Botulinum Toxin Recently Approved in US, Expands to Malaysia

All

Sorry, No Posts Found

All

Allergan Aesthetics Receives Positive CHMP Opinion for TrenibotulinumtoxinE for Glabellar Lines

The botulinum neurotoxin type E candidate is designed for a faster onset and shorter duration of effect than currently available neurotoxin treatments.

Plastic Surgery Among Specialties with Highest Surgeon Attrition Rates
Helium Plasma RF-Assisted Liposuction Linked to Higher Patient Satisfaction, Fewer Revisions
Researchers Push for Common Language Around Skin Quality in Aesthetic Medicine

Tag: daxibotulinumtoxina

All

Revance Reports Q4 and Full Year 2021 Financial Results; Credits Dermal Filler Sales for Growth

Revance Resubmits BLA to FDA for DaxibotulinumtoxinA for Injection

Aesthetic Surgeon Shares Insights on DAXI’s Potential

Letybo, a Botulinum Toxin Recently Approved in US, Expands to Malaysia

All

Sorry, No Posts Found

All

Allergan Aesthetics Receives Positive CHMP Opinion for TrenibotulinumtoxinE for Glabellar Lines

Plastic Surgery Among Specialties with Highest Surgeon Attrition Rates

Helium Plasma RF-Assisted Liposuction Linked to Higher Patient Satisfaction, Fewer Revisions

Researchers Push for Common Language Around Skin Quality in Aesthetic Medicine

Sorry, No Posts Found

Plastic Surgery Practice

Our Parent Company

Key Resources

Helpful Links